Description
What is Semax?
Semax is a synthetic peptide based on a fragment of ACTH (adrenocorticotropic hormone) — specifically the 4-10 portion — with an added Pro-Gly-Pro tail that increases stability and duration. Developed at the Institute of Molecular Genetics in Russia, it has been studied extensively as a nootropic — a compound that may enhance cognitive function.
Semax is notable for its influence on brain-derived neurotrophic factor (BDNF) — a protein critical for the growth, survival, and plasticity of brain cells. This mechanism sits at the heart of its research profile.
What Researchers Are Exploring
Cognitive Enhancement & Memory Semax’s primary research focus is cognitive function. Studies have shown it may enhance memory formation, learning capacity, and mental focus — effects linked to its upregulation of BDNF and influence on dopaminergic and serotonergic systems.
Neuroplasticity & BDNF Research has demonstrated that Semax significantly increases BDNF expression. BDNF is essential for neuroplasticity — the brain’s ability to form new connections and adapt — and is considered central to Semax’s cognitive effects.
Neuroprotection Studies have explored Semax’s ability to protect brain cells from damage caused by reduced blood flow, oxidative stress, and neurological insults — relevant to stroke recovery and neurodegenerative research.
Mood & Stress Response Research has examined its effects on mood regulation through serotonin and dopamine metabolism — with studies suggesting it may support emotional resilience under stress.
Worth Noting Semax has achieved regulatory approval in Russia for neurological conditions, giving it a clinical evidence base. Its ability to directly increase BDNF distinguishes it from most nootropic compounds and gives it a strong mechanistic foundation.
For research use only. Not intended for human consumption. Not approved by the FDA or TGA.
